Altered chemokine receptor sensitivity in FVBN202 rat neu transgenic mice

Breast Cancer Research and Treatment

Volumn 77, Issue 3, 2003, Pages 225-232

  Kurt, Robert A ^a   Bauck, Marissa ^a   Harma, Sarah ^a   Adler, Evan ^a   Vitiello, Peter ^a   Wisner, Ketura Preya ^b   Tackitt, Shane ^b   Urba, Walter J ^b  

^a LAFAYETTE COLLEGE   (United States)

^b EARLE A CHILES RESEARCH INSTITUTE   (United States)

Author keywords

Chemokine receptors; Chemokines; T cells; Tumor immunity

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; GLYCOPROTEIN P 15095;

ANIMAL CELL; ARTICLE; BREAST CANCER; CHEMOTAXIS; CONTROLLED STUDY; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD3; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LYMPHOCYTE ACTIVATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; RATS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES;

EID: 0037320795     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021853202515     Document Type: Article

References (18)

1. Peng L, Shu S, Krauss JC: Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells. Cancer Res 57: 4849-4854, 1997
2. Mrowietz U, Schwenk U, Maune S, Bartels J, Kupper M, Fichter I, Schroder JM, Schadendorf D: The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 79: 1025-1031, 1999
3. Youngs SJ, Ali SA, Taub DD, Rees RC: Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71: 257-266, 1997
4. Kurt RA, Baher A, Wisner KP, Tackitt S, Urba WJ: Chemokine receptor desensitization in tumor-bearing mice. Cell Immunol 207: 81-88, 2001
5. Guy CT, Webster MA, Schaller M, Parsons TJ, Carl RD, Muller WJ: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Nat Acad Sci (Wash) 89: 10578-10582, 1992
6. Kurt RA, Whitaker R, Baher A, Seung S, Urba WJ: Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice. Int J Cancer 87: 688-694, 2000
7. Morris AJ, Malbon CC: Physiological regulation of G protein-linked signaling. Phys Rev 79: 1373-1429, 1999
8. Saeki H, Moore AM, Brown MJ, Hwang ST: Secondary lymphoid tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162: 2472-2475, 1999
9. Campbell JJ, Junliang P, Butcher EC: Developmental switches in chemokine responses during T cell maturation. J Immunol 163: 2353-2357, 1999
10. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT: A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95: 258-263, 1998
11. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ: High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 155: 4838-4843, 1995
12. Lukacs NW, Kunkel SL, Strieter RM, Chensue SW: The role of chemokines in schistosoma mansoni granuloma formation. Parasit Today 10: 322-324, 1994
13. Dabbagh K, Xiao Y, Smith C, Stepick-Biek P, Kim SG, Lamm WJ, Liggitt DH, Lewis DB: Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI. J Immunol 165: 3418-3422, 2000
14. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ: CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617-7624, 2001
15. Neumark E, Anavi R, Witz IP, Ben-Baruch A: MCP-1 expression as a potent contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells. Immunol Lett 68: 141-146, 1999
16. Bacon KB, Premack BA, Gardner P, Schall TJ: Activation of dual signaling pathways by the chemokine RANTES. Science 269: 1727-1730, 1995
17. Appay V, Dunbar PR, Cerundolo V, McMichael A, Czaplewski L, Rowland-Jones S: RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. Int Immunol 12: 1173-1182, 2000
18. Zou W, Machelon V, Coulomb-L'Herman A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanaud P, Capron F, Emilie D, Curiel TJ: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7: 1339-1346, 2001